Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics by Elena Iemma | Sep 12, 2023
Immunogenicity risk assessment of synthetic peptide drugs and their impurities by Elena Iemma | Jul 27, 2023Immunogenicity risk assessment of synthetic peptide drugs and their impurities – ScienceDirect
Poster: Innovative preclinical assessment tools for safety and efficacy of protein and peptide therapeutics… Of Peptides and P-ANDAS by Elena Iemma | Sep 22, 2022Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics… of Peptides and P-ANDAS
